What is behind China’s rapid rise as a pharmaceutical powerhouse? (www.channelnewsasia.com)
from schizoidman@lemmy.zip to world@lemmy.world on 25 Feb 13:47
https://lemmy.zip/post/59750981

According to Goldman Sachs Research, 46 per cent of new drug molecules entering human trials worldwide in the first half of 2025 came from Chinese biopharma companies.

Official figures show that Chinese pharmaceutical companies signed 94 out-licensing deals in 2024. In 2025, that number surged to 157.

The value of those deals rose even faster, more than doubling from nearly US$52 billion to US$136 billion in just one year.

#world

threaded - newest

TotallynotJessica@lemmy.blahaj.zone on 25 Feb 17:29 collapse

They beat the US at their own game. They did capitalism and empire building better and the US will likely not even take the right lessons from it. Authoritarianism is here to stay in America, and the worst part is it won’t even work unless their opponents fail harder than them.